FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

Ronald Boellaard*, Mike J. O'Doherty, Wolfgang A. Weber, Felix M. Mottaghy, Markus N. Lonsdale, Sigrid G. Stroobants, Wim J. G. Oyen, Joerg Kotzerke, Otto S Hoekstra, Jan Pruim, Paul K. Marsden, Klaus Tatsch, Corneline J Hoekstra, Eric P. Visser, Bertjan Arends, Fred J. Verzijlbergen, Josee M. Zijlstra, Emile F. I. Comans, Adriaan A. Lammertsma, Anne M. PaansAntoon T. Willemsen, Thomas Beyer, Andreas Bockisch, Cornelia M. Schaefer-Prokop, Dominique Delbeke, Richard P. Baum, Arturo Chiti, Bernd J. Krause

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about[18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out,interpret, and document quantitative FDG PET/CT examinations,but will concentrate on the optimisation of diagnostic quality and quantitative information.
Original languageEnglish
Pages (from-to)181-200
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Issue number1
Publication statusPublished - Jan 2010


  • Guideline
  • FDG
  • PET
  • PET/CT
  • Tumour
  • Oncology
  • Quantification
  • QC
  • QA

Cite this